Envisagenics
Pre-clinicalRNA Therapeutics Development
Founded
2014
Focus
AI / Machine LearningGenetics & Genomics
About
RNA Therapeutics Development
Funding History
2Total raised: $7.5M
Series A$6MDynamk CapitalSep 15, 2020
Seed$1.5MUndisclosedJun 15, 2017
Company Info
TypePrivate
Founded2014
LocationNew York, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile